These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 38631147)

  • 1. High risk and low prevalence diseases: Stevens Johnson syndrome and toxic epidermal necrolysis.
    van Nispen C; Long B; Koyfman A
    Am J Emerg Med; 2024 Jul; 81():16-22. PubMed ID: 38631147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Lerch M; Mainetti C; Terziroli Beretta-Piccoli B; Harr T
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):147-176. PubMed ID: 29188475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of toxic epidermal necrolysis by a multidisciplinary team. A review of literature and treatment results.
    Papp A; Sikora S; Evans M; Song D; Kirchhof M; Miliszewski M; Dutz J
    Burns; 2018 Jun; 44(4):807-815. PubMed ID: 29627131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stevens-Johnson syndrome and toxic epidermal necrolysis-challenges of recognition and management.
    Sane SP; Bhatt AD
    J Assoc Physicians India; 2000 Oct; 48(10):999-1003. PubMed ID: 11200928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stevens-johnson Syndrome and Toxic Epidermal Necrolysis: An Overview of Diagnosis, Therapy Options and Prognosis of Patients.
    Garg VK; Buttar HS; Bhat SA; Ainur N; Priya T; Kashyap D; Tuli HS
    Recent Adv Inflamm Allergy Drug Discov; 2023; 17(2):110-120. PubMed ID: 37605396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bullous fixed drug eruption masquerading as recurrent Stevens Johnson syndrome.
    Dharamsi FM; Michener MD; Dharamsi JW
    J Emerg Med; 2015 May; 48(5):551-4. PubMed ID: 25433836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxic epidermal necrolysis and Stevens-Johnson syndrome.
    Harr T; French LE
    Orphanet J Rare Dis; 2010 Dec; 5():39. PubMed ID: 21162721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving mortality outcomes of Stevens Johnson syndrome/toxic epidermal necrolysis: A regional burns centre experience.
    Nizamoglu M; Ward JA; Frew Q; Gerrish H; Martin N; Shaw A; Barnes D; Shelly O; Philp B; El-Muttardi N; Dziewulski P
    Burns; 2018 May; 44(3):603-611. PubMed ID: 29029855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nine years of a single referral center management of Stevens-Johnson syndrome and toxic epidermal necrolysis (Lyell's syndrome).
    Monteiro D; Egipto P; Barbosa J; Horta R; Amarante J; Silva P; Silva A
    Cutan Ocul Toxicol; 2017 Jun; 36(2):163-168. PubMed ID: 27487073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxic epidermal necrolysis and Stevens-Johnson syndrome/toxic epidermal necrolysis overlap in pediatric patients with a focus on newer antiepileptic drugs: A 25-year retrospective study at a single tertiary care center.
    Gleghorn KL; Voigt C; Kelly B
    Pediatr Dermatol; 2021 Jul; 38(4):812-818. PubMed ID: 34060145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of Drug-Induced Epidermal Necrolysis (DEN) in Pediatric Patients: Moving from Drug-Induced Stevens-Johnson Syndrome, Overlap and Toxic Epidermal Necrolysis to a Single Unifying Diagnosis of DEN.
    Ramien ML; Mansour D; Shear NH
    Paediatr Drugs; 2022 Jul; 24(4):307-319. PubMed ID: 35676614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in Treatment of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis at Burn Centers and Nonburn Centers.
    Nygaard RM; Endorf FW
    J Burn Care Res; 2020 Sep; 41(5):945-950. PubMed ID: 32498082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genitourinary involvement and management in children with Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Van Batavia JP; Chu DI; Long CJ; Jen M; Canning DA; Weiss DA
    J Pediatr Urol; 2017 Oct; 13(5):490.e1-490.e7. PubMed ID: 28314701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stevens-Johnson syndrome and toxic epidermal necrolysis: a 10-year experience in a burns unit.
    Houschyar KS; Tapking C; Borrelli MR; Nietzschmann I; Puladi B; Ooms M; Rein S; Houschyar M; Duscher D; Maan ZN; Reumuth G; Branski LK; Modabber A; Kluwig D; Schmitt L; Philipp-Dormston WG; Yazdi AS; Siemers F
    J Wound Care; 2021 Jun; 30(6):492-496. PubMed ID: 34121430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxic epidermal necrolysis and Stevens-Johnson syndrome after COVID-19 infection and vaccination.
    Zou H; Daveluy S
    Australas J Dermatol; 2023 Feb; 64(1):e1-e10. PubMed ID: 36484649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinguishing Stevens-Johnson syndrome/toxic epidermal necrolysis from clinical mimickers during inpatient dermatologic consultation-A retrospective chart review.
    Weinkle A; Pettit C; Jani A; Keller J; Lu Y; Malachowski S; Trinidad JC; Kaffenberger BH; Ergen EN; Hughey LC; Smith D; Seminario-Vidal L
    J Am Acad Dermatol; 2019 Sep; 81(3):749-757. PubMed ID: 31150704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A decade of burn unit experience with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: Clinical pathological diagnosis and risk factor awareness.
    Lim VM; Do A; Berger TG; Nguyen AH; DeWeese J; Malone JD; Jordan K; Hom F; Tuffanelli L; Fillari P; Siu S; Grossman R
    Burns; 2016 Jun; 42(4):836-43. PubMed ID: 26847613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in managing and understanding Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Hasegawa A; Abe R
    F1000Res; 2020; 9():. PubMed ID: 32595945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Society of Dermatology Hospitalists supportive care guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults.
    Seminario-Vidal L; Kroshinsky D; Malachowski SJ; Sun J; Markova A; Beachkofsky TM; Kaffenberger BH; Ergen EN; Mauskar M; Bridges A; Calhoun C; Cardones AR; Chen ST; Chodosh J; Cotliar J; Davis MDP; DeNiro KL; Dominguez AR; Eljure-Téllez J; Femia A; Fox LP; Guda A; Mitchell C; Mostaghimi A; Ortega-Loayza AG; Owen C; Pasieka H; Rahnama-Moghadam S; Saeed HN; Saunderson RB; Shanbhag S; Sharon VR; Strowd L; Venkatesh S; Wanat KA; Wetter DA; Worswick S; Micheletti RG
    J Am Acad Dermatol; 2020 Jun; 82(6):1553-1567. PubMed ID: 32151629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Patients Treated With a Medicine-Led Multidisciplinary Approach.
    Lewcun JA; Vagonis A; Kontzias C; Newsom M; Drake M; Feldman MJ
    J Burn Care Res; 2024 Jan; 45(1):165-168. PubMed ID: 37698266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.